Sublocade FDA Approval History
FDA Approved: Yes (First approved November 30, 2017)
Brand name: Sublocade
Generic name: buprenorphine
Dosage form: Sustained-Release Injection
Previous Name: RBP-6000
Company: Indivior PLC
Treatment for: Opiate Dependence
Sublocade (buprenorphine) is a once-monthly injectable partial opioid agonist formulation for the treatment of opioid use disorder (OUD).
Development timeline for Sublocade
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.